Difference between revisions of "MR Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
:Chairs: Michael Boss, PhD (Co-Chair); Caroline Chung, MD (Co-Chair); Cathy Elsinger, PhD (Co-chair)
+
:Co-Chairs: Michael Boss, PhD; Thomas L. Chenevert, PhD; Caroline Chung, MD; Cathy Elsinger, PhD
 
:RSNA Staff Support: Susan Stanfa
 
:RSNA Staff Support: Susan Stanfa
 
[https://docs.google.com/spreadsheets/d/e/2PACX-1vReaE9KRKRnlwhq95r9wrvLzVcZMg5iehJatSFB4ZtrDgP99-Fg-kT1Mqiqhxj6IkUDgFqF-jItmXEO/pubhtml?gid=1050413002&single=true Roster]
 
[https://docs.google.com/spreadsheets/d/e/2PACX-1vReaE9KRKRnlwhq95r9wrvLzVcZMg5iehJatSFB4ZtrDgP99-Fg-kT1Mqiqhxj6IkUDgFqF-jItmXEO/pubhtml?gid=1050413002&single=true Roster]

Revision as of 18:51, 26 January 2021

Co-Chairs: Michael Boss, PhD; Thomas L. Chenevert, PhD; Caroline Chung, MD; Cathy Elsinger, PhD
RSNA Staff Support: Susan Stanfa

Roster


Scope

The MR Coordinating Committee coordinates Biomarker Committees based on MR.

  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the MR Biomarker Committees


Meetings

  • Tcons are held Quarterly. Contact RSNA Staff for details.